-
A drug maker accused of using bribes and kickbacks to encourage doctors to prescribe a highly addictive opioid painkiller has won a partial reprieve in federal court.
-
The company agreed to make the payments to resolve federal criminal and civil investigations of its marketing practices. Five of its executives were convicted separately for the same practices.